Literature DB >> 3006554

Midazolam infusion for sedation in the intensive care unit: effect on adrenal function.

J M Shapiro, L M Westphal, P F White, R N Sladen, M H Rosenthal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006554     DOI: 10.1097/00000542-198603000-00022

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  8 in total

Review 1.  Assisted ventilation. 3. General care of the ventilated patient in the intensive care unit.

Authors:  M R Hamilton-Farrell; G C Hanson
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

Review 2.  Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil.

Authors:  R Amrein; W Hetzel
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting.

Authors:  F Snellen; P Lauwers; R Demeyere; G Byttebier; H Van Aken
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  Cardiovascular effects of intravenous midazolam after open heart surgery.

Authors:  L Shekerdemian; A Bush; A Redington
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

Review 5.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

6.  Midazolam infusion for basal sedation in intensive care: absence of accumulation.

Authors:  S Michalk; C Moncorge; A Fichelle; O Huot; F Servin; R Farinotti; J M Desmonts
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  Midazolam for sedation in the paediatric intensive care unit.

Authors:  D A Rosen; K R Rosen
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

8.  Pharmacokinetics of midazolam in patients recovering from cardiac surgery.

Authors:  P O Maitre; B Funk; C Crevoisier; H R Ha
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.